EURORECERCA NÚM 793

Fecha: 22 de agosto de 2011

SUBSCRIPCIONES

Compartir

 

La Comisión Europea ha publicado, con fecha 20 de julio de 2011, dos convocatorias del tema "Salud" del programa de Cooperación del Séptimo Programa Marco europeo de I+D. Estas convocatorias pertenecen al Programa de Trabajo 2012 (ftp://ftp.cordis.europa.eu/pub/fp7/docs/wp/cooperation/health/a-wp-201201_en.pdf).

La información completa de la convocatoria la encontraréis haciendo clic en el código. Si tenéis problemas de acceso con el enlace, podéis cortar y pegar la dirección en vuestro navegador.

El plazo de presentación de propuestas finaliza el día señalado a las 17 horas (hora local de Bruselas).

PROGRAMA ESPECÍFICO DE COOPERACIÓN

FP7-HEALTH-2012-INNOVATION-1
http://ec.europa.eu/research/participants/portal/page/cooperation?callIdentifier=FP7-HEALTH-2012-INNOVATION-1
Presupuesto indicativo: 546.000.000 euros.
Fecha límite: 4 d'octubre de 2011.
Temas convocados: 1. BIOTECHNOLOGY, GENERIC TOOLS AND MEDICAL TECHNOLOGIES FOR HUMAN HEALTH. 1.2 DETECTION, DIAGNOSIS & MONITORING. HEALTH.2012.1.2-1: Development of technologies with a view to patient group stratification for personalised medicine applications. 1.4 INNOVATIVE THERAPEUTIC APPROACHES AND INTERVENTIONS. HEALTH.2012.1.4-1: Innovative approaches to solid organ transplantation. HEALTH.2012.1.4-3: Innovative Strategies for translation of stem cell based therapies in regenerative medicine (European Union-Australia cooperation). HEALTH.2012.1.4-4: Targeted nucleic acid delivery as an innovative therapeutic or prophylactic approach. 2. TRANSLATING RESEARCH FOR HUMAN HEALTH. 2.1 INTEGRATING BIOLOGICAL DATA AND PROCESSES: LARGE-SCALE DATA GATHERING, SYSTEMS BIOLOGY. 2.1.1 Large-scale data gathering. 2.1.1.1 –Omics for rare diseases. HEALTH.2012.2.1.1.1-A: Support for international rare disease research. HEALTH.2012.2.1.1.1-B: Clinical utility of -omics for better diagnosis of rare diseases. HEALTH.2012.2.1.1.1-C: Databases, biobanks and 'clinical bio-informatics' hub for rare diseases. HEALTH.2012.2.1.1-2: Validation of -omics-based biomarkers for diseases affecting the elderly. HEALTH.2012.2.1.1-3: Statistical methods for collection and analysis of -omics data. 2.1.2 Systems biology. HEALTH.2012.2.1.2-1: Systems medicine: SME-driven research applying systems biology approaches to address medical and clinical needs. HEALTH.2012.2.1.2-2: Systems medicine: Applying systems biology approaches for understanding multifactorial human diseases and their co-morbidities. HEALTH.2012.2.1.2-3: Preparing for the future research and innovation activities in systems medicine. 2.2 RESEARCH ON THE BRAIN AND RELATED DISEASES, HUMAN DEVELOPMENT AND AGEING 2.2.2 Human development and ageing. HEALTH.2012.2.2.2-1: Integrative systems biology and comparative genomics for studying human ageing and/or most common age-related diseases. HEALTH.2012.2.2.2-2: Investigator-driven clinical trials for optimisation of management of elderly patients with multiple diseases. 2.3 TRANSLATIONAL RESEARCH IN MAJOR INFECTIOUS DISEASES: TO CONFRONT MAJOR THREATS TO PUBLIC HEALTH. 2.3.2 HIV/AIDS, malaria and tuberculosis. HEALTH.2012.2.3.2-1: Co-infection of HIV/AIDS, malaria, tuberculosis and/or hepatitis. HEALTH.2012.2.3.2-2: Co-morbidity between infectious and non-communicable diseases. HEALTH.2012.2.3.2-3: Prevention and treatment for HIV/AIDS, malaria and tuberculosis. HEALTH.2012.2.3.2-4: Low-cost interventions for disease control in resource poor settings. 2.4 TRANSLATIONAL RESEARCH IN OTHER MAJOR DISEASES 2.4.3 Diabetes and obesity. HEALTH.2012.2.4.3-1: Innovative approach to manage diabetes. HEALTH.2012.2.4.3-2: Investigator-driven clinical trials for type 1 diabetes research. 2.4.4 Rare diseases. HEALTH.2012.2.4.4-1: Preclinical and/or clinical development of substances with a clear potential as orphan drugs. HEALTH.2012.2.4.4-2: Observational trials in rare diseases. HEALTH.2012.2.4.4-3: Best practice and knowledge sharing in the clinical management of rare diseases. 2.4.5 Other chronic diseases. HEALTH.2012.2.4.5-2: Biomarkers and diagnostics for chronic inflammatory diseases of the joints and/or digestive system. 3. OPTIMISING THE DELIVERY OF HEALTHCARE TO EUROPEAN CITIZENS 3.2 QUALITY, EFFICIENCY AND SOLIDARITY OF HEALTH CARE SYSTEMS INCLUDING TRANSITIONAL HEALTH SYSTEMS. HEALTH.2012.3.2-1: Improving the organisation of health service delivery. HEALTH.2012.3.2-2: New methodologies for health technology assessment. HEALTH.2012.3.2-3: Social innovation for active and healthy ageing. 3.4 INTERNATIONAL PUBLIC HEALTH & HEALTH SYSTEMS. HEALTH.2012.3.4-1: Research on health systems and services in low- and middle-income countries. 4. OTHER ACTIONS ACROSS THE HEALTH THEME 4.1 COORDINATION AND SUPPORT ACTIONS ACROSS THE THEME. HEALTH.2012.4.1-1: Network to encourage knowledge transfer activity in FP-funded health research (especially in academic and governmental organisations). HEALTH.2012.4.1-2: Training actions linked to intellectual property rights management and knowledge transfer. HEALTH.2012.4.1-3: Support for Presidency events: Organisation of supporting actions and events related to the Presidency of the European Union. HEALTH.2012.4.1-4: Communicating the benefits of European research to the general public. HEALTH.2012.4.1-5: Preparing the future for health research and innovation. HEALTH.2012.4.1-6: Setting healthrelated development goals beyond 2015.

Esquema de financiación: diferentes según el tema, consultad el texto completo de la convocatoria.

FP7-HEALTH-2012-INNOVATION-2 SMEs-FOR-INNOVATION

http://ec.europa.eu/research/participants/portal/page/cooperation?callIdentifier=FP7-HEALTH-2012-INNOVATION-2

Presupuesto indicativo: 108.000.000 euros.
Fecha límite: convocatòria en dues fases. Data límit de la primera fase: 27 de setembre de 2011.
Temas convocados: 1. BIOTECHNOLOGY, GENERIC TOOLS AND MEDICAL TECHNOLOGIES FOR HUMAN HEALTH. 1.4 INNOVATIVE THERAPEUTIC APPROACHES AND INTERVENTIONS. HEALTH.2011.1.4-2: Medical technology for transplantation and bioartificial organs. 2.3. TRANSLATIONAL RESEARCH IN MAJOR INFECTIOUS DISEASES: TO CONFRONT MAJOR THREATS TO PUBLIC HEALTH. 2.3.0 Cross-cutting. HEALTH.2012.2.3.0-1: Diagnostics for infectious diseases in humans. 2.4 TRANSLATIONAL RESEARCH IN OTHER MAJOR DISEASES. 2.4.3 Other chronic diseases. HEALTH.2012.2.4.5-1: Technological approaches to combating sensory impairments.

Esquema de financiación: proyectos colaborativos de pequeña o mediana escala.

 

 

Este mensaje se ha distribuido a la lista EUROSALUT (Oficina Proyectos Europeos UV). Para subscribirse, envíe un mensaje a la dirección listserv@listserv.uv.es con el texto siguiente: subscribe EUROSALUT Nombre Apellidos. Para cancelar la subscripción, envíe un mensaje a la dirección listserv@listserv.uv.es con el texto: signoff EUROSALUT.